Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01501487
Title MINT I Multi- Institutional Neo-adjuvant Therapy MammaPrint Project I
Recruitment Completed
Gender female
Phase FDA approved
Variant Requirements No
Sponsors Agendia
Indications

breast cancer

Therapies

Cyclophosphamide + Docetaxel + Doxorubicin

Cyclophosphamide + Epirubicin + Fluorouracil

Paclitaxel

Pegfilgrastim

Cyclophosphamide + Docetaxel

Cyclophosphamide + Doxorubicin

Carboplatin + Docetaxel + Trastuzumab

Docetaxel + Pertuzumab + Trastuzumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.